Posts in category

Mortgage Blog


Cancer treatment breakthroughs seem to come at a rapid pace these days. From genetic testing to targeted immunotherapy treatments and revolutionary drugs, many cancer patients have hope for better outcomes. All too often, however, these better outcomes are only available to a select few—those with knowledge, money and good insurance.

One Danville organization, begun in 2006, works tirelessly to change that paradigm with innovative ideas and an unorthodox approach to solving the problems associated…

St. Jude pledged another $50M to fund Blue-Sky projects generated by staffers. The initiative seeks to prompt employees and faculty to push forward bold ideas.

More than a year after formation, Phoenix-based Integro Bank is expanding with a new mortgage lending division. The bank's CEO spoke to the Business Journal about the strategy behind the move.

Jared Muenzer, M.D., will retain his job as chief operating officer of Phoenix Children's as he accepts additional C-suite responsibilities at the health network.

Contract research organization operates turnkey vivariums for drug research involving animals.

Rocky Mount's Providence Bank will absorb Coastal Bank & Trust to create a $1.1 billion institution, signaling the return of M&A, which has been stagnant for the past few years in North Carolina.

Former lawmaker and prison chief Max Williams sees a lot of value in funneling money to treatment, but thinks there ought to be more consequences for drug possession.

WASHINGTON – The Biden administration targeted 10 prescription drugs Tuesday as part of the first-ever Medicare price negotiation, a move that it said could benefit 9 million beneficiaries – including 165,000 in Arizona.

The medications, which are used to treat heart failure, blood clots, diabetes, arthritis, Crohn’s disease and more, account for the highest spending for drugs in Medicare Part D, and cost Medicare enrollees an estimated $3.4 billion in out-of-pocket expenses last year.

The…

A Durham company that develops technology supporting research into cell biology is looking to expand its revenue sources in the U.S. and abroad.